Skip to main
PLXS
PLXS logo

Plexus (PLXS) Stock Forecast & Price Target

Plexus (PLXS) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 15%
Hold 46%
Sell 8%
Strong Sell 0%

Bulls say

Plexus Corp has demonstrated a robust 15% year-over-year increase in Healthcare/Life Sciences (HCLS) new program wins, amounting to $130 million, indicating strong demand and growth prospects in this key segment. The company's return on invested capital (ROIC) has improved to 13.8%, reflecting enhanced operational efficiency and profitability compared to the prior quarter. Furthermore, a significant turnaround in free cash flow, rising to $27 million from a negative $32 million a year ago, along with an increased FY25 outlook for free cash flow to $100 million, underscores the company's financial strength and positive operational trajectory.

Bears say

Plexus Corp reported a revenue decline of 1% year-over-year to $976 million, falling short of both guidance and market expectations. The company anticipates flat sequential revenue in the upcoming quarter, primarily due to significant weakness in its Industrial segment, which is projected to decline by high single to low double digits. Additionally, free cash flow sharply decreased to $27 million in the first quarter, down from $194 million in the previous quarter, indicating potential cash flow challenges ahead.

Plexus (PLXS) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 15% recommend Buy, 46% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Plexus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Plexus (PLXS) Forecast

Analysts have given Plexus (PLXS) a Buy based on their latest research and market trends.

According to 13 analysts, Plexus (PLXS) has a Buy consensus rating as of Jul 6, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $95.77, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $95.77, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Plexus (PLXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.